John Patton

John Patton

Fondatore presso
Aerami Therapeutics Holdings, Inc.
79 anni
Health Technology
Consumer Services
Commercial Services

Profilo

John Stuart Patton was the founder of Nektar Therapeutics, founded in 1990, where he held the title of Director & Chief Scientific Officer from 1990 to 2008.
He was also the founder of InCarda Therapeutics, Inc., founded in 2009, where he served as Chairman from 2009 to 2011.
Additionally, Dr. Patton is the founder of Aerami Therapeutics, Inc., founded in 2009, where he currently holds the title of Director.
Dr. Patton is also the founder of Aerami Therapeutics Holdings, Inc...
Dr. Patton's former jobs include being an Independent Director at Halozyme Therapeutics, Inc. from 1990 to 2015, a Director at Saegis Pharmaceuticals, Inc., a Director-Supervisory Board at Vectura GmbH from 2007 to 2014, and a Scientist at Genentech, Inc. in 1990.
He also held a position as a Professor at the University of Georgia.
In terms of education, Dr. Patton obtained a graduate degree from the University of Rhode Island, an undergraduate degree from The Pennsylvania State University, and a doctorate degree from the University of California San Diego.

Posizioni attive di John Patton

SocietàPosizioneInizio
Fondatore -
Fondatore 01/01/2016

Precedenti posizioni note di John Patton

SocietàPosizioneFine
HALOZYME THERAPEUTICS, INC. Direttore/Membro del Consiglio 06/05/2015
Direttore/Membro del Consiglio 01/03/2014
Direttore/Membro del Consiglio 17/02/2009
NEKTAR THERAPEUTICS Fondatore 21/11/2008
Direttore Tecnico/Scientifico/R&S 01/01/1990
Vedi nel dettaglio l'esperienza di John Patton

Formazione di John Patton

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

64

Relazioni di 1° grado

13

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private13

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Consumer Services

Health Technology

Commercial Services

Health Technology

Health Technology

Commercial Services

  1. Mercati
  2. Insiders
  3. John Patton
- 40%: I migliori strumenti riservati agli abbonati per individuare le opportunità di investimento di domani.
g
:
:
ENTRA ORA